Literature DB >> 11141480

Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice.

K D Bornemann1, K H Wiederhold, C Pauli, F Ermini, M Stalder, L Schnell, B Sommer, M Jucker, M Staufenbiel.   

Abstract

A microglial response is part of the inflammatory processes in Alzheimer's disease (AD). We have used APP23 transgenic mice overexpressing human amyloid precursor protein with the Swedish mutation to characterize this microglia response to amyloid deposits in aged mice. Analyses with MAC-1 and F4/80 antibodies as well as in vivo labeling with bromodeoxyuridine demonstrate that microglia in the plaque vicinity are in an activated state and that proliferation contributes to their accumulation at the plaque periphery. The amyloid-induced microglia activation may be mediated by scavenger receptor A, which is generally elevated, whereas the increased immunostaining of the receptor for advanced glycation end products is more restricted. Although components of the phagocytic machinery such as macrosialin and Fc receptors are increased in activated microglia, efficient clearance of amyloid is missing seemingly because of the lack of amyloid-bound autoantibodies. Similarly, although up-regulation of major histocompatibility complex class II (IA) points toward an intact antigen-presenting function of microglia, lack of T and B lymphocytes does not indicate a cell-mediated immune response in the brains of APP23 mice. The similar characteristics of microglia in the APP23 mice and in AD render the mouse model suitable to study the role of inflammatory processes during AD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11141480      PMCID: PMC1850262          DOI: 10.1016/s0002-9440(10)63945-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

Review 1.  Fc receptors.

Authors:  J V Ravetch; J P Kinet
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 2.  Inflammatory mechanisms in Alzheimer's disease.

Authors:  P Eikelenboom; S S Zhan; W A van Gool; D Allsop
Journal:  Trends Pharmacol Sci       Date:  1994-12       Impact factor: 14.819

3.  F4/80, a monoclonal antibody directed specifically against the mouse macrophage.

Authors:  J M Austyn; S Gordon
Journal:  Eur J Immunol       Date:  1981-10       Impact factor: 5.532

4.  Activation of microglial cells by beta-amyloid protein and interferon-gamma.

Authors:  L Meda; M A Cassatella; G I Szendrei; L Otvos; P Baron; M Villalba; D Ferrari; F Rossi
Journal:  Nature       Date:  1995-04-13       Impact factor: 49.962

5.  Role of microglia in senile plaque formation.

Authors:  I R Mackenzie; C Hao; D G Munoz
Journal:  Neurobiol Aging       Date:  1995 Sep-Oct       Impact factor: 4.673

6.  Activation of macrophages by Alzheimer beta amyloid peptide.

Authors:  A Klegeris; D G Walker; P L McGeer
Journal:  Biochem Biophys Res Commun       Date:  1994-03-15       Impact factor: 3.575

Review 7.  Microglia in degenerative neurological disease.

Authors:  P L McGeer; T Kawamata; D G Walker; H Akiyama; I Tooyama; E G McGeer
Journal:  Glia       Date:  1993-01       Impact factor: 7.452

8.  Structural heterogeneity and functional domains of murine immunoglobulin G Fc receptors.

Authors:  J V Ravetch; A D Luster; R Weinshank; J Kochan; A Pavlovec; D A Portnoy; J Hulmes; Y C Pan; J C Unkeless
Journal:  Science       Date:  1986-11-07       Impact factor: 47.728

9.  Differential expression of murine macrophage surface glycoprotein antigens in intracellular membranes.

Authors:  M J Smith; G L Koch
Journal:  J Cell Sci       Date:  1987-02       Impact factor: 5.285

10.  Function and regulation of a murine macrophage-specific IgG Fc receptor, Fc gamma R-alpha.

Authors:  R L Weinshank; A D Luster; J V Ravetch
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

View more
  74 in total

Review 1.  APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).

Authors:  R Lalonde; K Fukuchi; C Strazielle
Journal:  Neurosci Biobehav Rev       Date:  2012-02-21       Impact factor: 8.989

Review 2.  Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.

Authors:  Elizabeth E Spangenberg; Kim N Green
Journal:  Brain Behav Immun       Date:  2016-07-06       Impact factor: 7.217

Review 3.  Transgenic mouse models of Alzheimer disease: developing a better model as a tool for therapeutic interventions.

Authors:  Masashi Kitazawa; Rodrigo Medeiros; Frank M Laferla
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

4.  Erythropoietin requires NF-kappaB and its nuclear translocation to prevent early and late apoptotic neuronal injury during beta-amyloid toxicity.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Curr Neurovasc Res       Date:  2005-12       Impact factor: 1.990

Review 5.  Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease.

Authors:  Zhao Zhong Chong; Faqi Li; Kenneth Maiese
Journal:  Brain Res Brain Res Rev       Date:  2005-01-08

6.  Adverse effect of a presenilin-1 mutation in microglia results in enhanced nitric oxide and inflammatory cytokine responses to immune challenge in the brain.

Authors:  Jaewon Lee; Sic L Chan; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

7.  Long-lasting impairment in hippocampal neurogenesis associated with amyloid deposition in a knock-in mouse model of familial Alzheimer's disease.

Authors:  Chen Zhang; Elizabeth McNeil; Lindsay Dressler; Robert Siman
Journal:  Exp Neurol       Date:  2006-10-27       Impact factor: 5.330

8.  SPION-enhanced magnetic resonance imaging of Alzheimer's disease plaques in AβPP/PS-1 transgenic mouse brain.

Authors:  Laurel O Sillerud; Nathan O Solberg; Ryan Chamberlain; Robert A Orlando; John E Heidrich; David C Brown; Christina I Brady; Thomas A Vander Jagt; Michael Garwood; David L Vander Jagt
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

9.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

Review 10.  What can rodent models tell us about cognitive decline in Alzheimer's disease?

Authors:  Sabrina Davis; Serge Laroche
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.